GlassScriptPhysician profile
Agam Patel
NPI 1629496484
$27,339.58
in general payments reported to CMS, 2019-2025
29 companies · $15K in 2025
The $15K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $1,797 · 2021: $2,885 · 2022: $712 · 2023: $2,029 · 2024: $4,525 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $19K · Food and Beverage: $1,412 · Travel and Lodging: $981 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $19,291.67 |
| Food and Beverage | $1,411.69 |
| Travel and Lodging | $981.25 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $19,344.73 | 2024-2025 | Auryon Laser System 100-120 Vac, Micro Access, Auryon Laser System 100-120 Vac |
| Edwards Lifesciences Corporation | $2,558.79 | 2021-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $2,106.22 | 2020-2022 | |
| Boston Scientific Corporation | $465.43 | 2020-2025 | Rotablator Rotational Atherectomy System Console Kit, General - Stents, Ranger |
| Penumbra, INC. | $375.73 | 2021 | |
| Janssen Pharmaceuticals, INC | $334.32 | 2021-2022 | |
| Cvrx, INC. | $201.52 | 2023 | Barostim Neo System |
| Cardiovascular Systems INC. | $193.84 | 2020-2023 | Diamondback Coronary |
| E.R. Squibb & Sons, L.L.C. | $188.96 | 2020-2022 | |
| Astellas Pharma US INC | $171.54 | 2020-2021 | |
| Amgen INC. | $152.55 | 2020-2024 | Repatha |
| Biotronik INC. | $152.00 | 2023 | Biomonitor |
| Medtronic, INC. | $116.07 | 2021-2022 | |
| Reflow Medical INC | $104.13 | 2024-2025 | |
| Pfizer INC. | $89.13 | 2021-2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $89.02 | 2020-2024 | Lokelma |
| Novartis Pharmaceuticals Corporation | $78.60 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $72.01 | 2022-2023 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $71.67 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.49 | 2022-2024 | Lifevest |
| Abiomed | $36.19 | 2025 | |
| Cardinal Health 200 LLC | $27.80 | 2021 | |
| Sanofi-Aventis U.S. LLC | $24.76 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.68 | 2023 | Jardiance |
| Chiesi USA, INC. | $17.31 | 2021 | |
| Philips North America LLC | $16.91 | 2023 | |
| Bard Peripheral Vascular, INC. | $16.69 | 2024 | |
| Verge Medical, INC. | $14.83 | 2021 | |
| Medtronic Vascular, INC. | $13.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Agam Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.